Trial
NCT02234037
Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
—
Condition
Leukemia
Intervention
Decitabine
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-30